Key result
Neutrophils directly mediate cardiac arrhythmias during myocardial ischemia and infection.
Why the study?
Recent studies have highlighted the role of innate immune cells and leukocyte expansion in cardiac arrhythmias, but the specific role of neutrophils as direct mediators of arrhythmogenicity warrants attention.
This review highlights the emerging understanding of neutrophils as direct mediators of arrhythmogenicity during myocardial ischemia and infection.
Neutrophil modulation merits exploration in arrhythmia models; hypothesis-generating without interventional data to guide practice.
Cardiac arrhythmias commonly occur as a result of aberrant electrical impulse formation or conduction in the myocardium. Frequently discussed triggers include underlying heart diseases such as myocardial ischemia, electrolyte imbalances, or genetic anomalies of ion channels involved in the tightly regulated cardiac action potential. Recently, the role of innate immune cells in the onset of arrhythmic events has been highlighted in numerous studies, correlating leukocyte expansion in the myocardium to increased arrhythmic burden. Here, we aim to call attention to the role of neutrophils in the pathogenesis of cardiac arrhythmias and their expansion during myocardial ischemia and infectious disease manifestation. In addition, we will elucidate molecular mechanisms associated with neutrophil activation and discuss their involvement as direct mediators of arrhythmogenicity.
No takes yet. Share an insight, caveat, or question.
Hegemann et al. (2023) conducted a review in Cardiac arrhythmias. Neutrophils play a significant role in the pathogenesis of cardiac arrhythmias, acting as direct mediators of arrhythmogenicity during myocardial ischemia and infectious diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: